Skip to main content

We are a dynamic multidisciplinary research group studying diabetic vasculopathies. We are part of the Center for Nanotechnology in Drug Delivery at the University of North Carolina – Chapel Hill. Our long term research aims to change the way we treat arterial disease in diabetes by:

  • Understanding why arterial disease is more aggressive in diabetic patients, with an emphasis in understanding the redox dysfunction in the vasculature.
  • Understanding howother causes of redox dysfunction such as air pollution affect vascular surgery outcomes.
  • Developing targeted systems using nanotechnology to locally deliver redox-based therapeutics to the diseased arteries.

[Learn more about our research]